|
PHARMACOKINETICS OF CEFTAZIDIME IN RABBITS
|
|
|
头孢他啶在兔体内的药代动力学 |
|
PHARMACOKINETICS OF CEFTIZOXIME IN HUMANS
|
|
|
头孢唑肟的人体药代动力学研究 |
|
PHARMACOKINETICS OF CLOZAPINE IN RABBITS
|
|
|
兔静注氯氮平药时数据的药代动力学分析 |
|
PHARMACOKINETICS OF CONTRAGESTAZOL(DL-111-IT),A NEW NON-STEROID
|
|
|
抗孕唑（DL－111－IT）在恒河猴体内药代动力学 |
|
PHARMACOKINETICS OF ERYSIMOSIDE G IN RABBITS
|
|
|
糖芥苷G在家兔体内药动学研究 |
|
PHARMACOKINETICS OF HEMATOPORPHYRIN MONOMETHYL ETHER (PsD-044) IN RABBITS
|
|
|
血卟啉单甲醚(PsD-044)在家兔体内的药物动力学 |
|
PHARMACOKINETICS OF MAGNESIUM GLUTAMATE IN RABBITS
|
|
|
谷氨酸镁在兔体内的药物动力学研究 |
|
PHARMACOKINETICS OF MEGESTROL ACETATE IN RABBITS AND RATS
|
|
|
甲地孕酮在家兔和大鼠的药物动力学 |
|
PHARMACOKINETICS OF MUSCONE IN RATS, RABBITS AND DOGS
|
|
|
麝香酮在大鼠、家兔和狗体内的药代动力学 |
|
PHARMACOKINETICS OF NITRENDIPINE IN RABBITS BY PLASMA HPLC ANALYSIS
|
|
|
HPLC测定家兔血浆中尼群地平及其药代动力学参数 |
|
PHARMACOKINETICS OF NORETHINDRONE-3-OXIME AND NORETHINDRONE IN RHESUS MONKEYS
|
|
|
炔诺酮肟(NETO)与炔诺酮(NET)在猴体内的药代动力学 |
